PCMNC
MRK icon

Piedmont Capital Management (North Carolina)’s Merck MRK Stock Holding History

Piedmont Capital Management (North Carolina)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$514K Sell
4,271
-253
-6% -$29.2K 0.34% 51
2025
Q4 		$476K Buy
+4,524
New +$425K 0.31% 50

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Piedmont Capital Management (North Carolina)'s MRK Position: Q1 2026 in Review

Piedmont Capital Management (North Carolina) reduced its Merck (MRK) stake by 5.6% in Q1 2026, selling an estimated $29.2K and leaving 4,271 shares worth $514K. The position accounts for 0.34% of the portfolio, ranked #51.

Piedmont Capital Management (North Carolina) first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Piedmont Capital Management (North Carolina) held 4,271 shares of Merck worth $514K as of Q1 2026.
  • Piedmont Capital Management (North Carolina) sold 253 Merck shares in Q1 2026, an estimated $29.2K.
  • Merck made up 0.34% of Piedmont Capital Management (North Carolina)'s portfolio in Q1 2026, its #51 holding.
  • Piedmont Capital Management (North Carolina) first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
  • 3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Piedmont Capital Management (North Carolina)'s 13F filing for Q1 2026, filed 21 Apr 2026.